128 related articles for article (PubMed ID: 9288579)
1. Comparison of a new anti-glutamic acid decarboxylase (GAD) enzyme-linked immunosorbent assay (ELISA) with radioimmunoassay methods: a multicenter study.
Wild T; Scherbaum WA; Gleichmann H; Landt M; Santiago J; Endl J; Landgraf R; Cavallo MG; Ganz M; Pozzilli P
Horm Metab Res; 1997 Aug; 29(8):403-6. PubMed ID: 9288579
[TBL] [Abstract][Full Text] [Related]
2. Glutamic acid decarboxylase autoantibodies in stiff-man syndrome and insulin-dependent diabetes mellitus exhibit similarities and differences in epitope recognition.
Daw K; Ujihara N; Atkinson M; Powers AC
J Immunol; 1996 Jan; 156(2):818-25. PubMed ID: 8543838
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies associated with presymptomatic insulin-dependent diabetes mellitus in women.
Whittingham S; Byron SL; Tuomilehto J; Zimmet PZ; Myers MA; Vidgren G; Rowley MJ; Feeney SJ; Koskela P; Tuomilehto-Wolf E; Mackay IR
Diabet Med; 1997 Aug; 14(8):678-85. PubMed ID: 9272595
[TBL] [Abstract][Full Text] [Related]
4. [IA-2 and anti-GAD antibodies in patients with newly diagnosed type 1 diabetes and their first degree relatives].
Kretowski A; Kowalska I; Peczyńska J; Urban M; Kinalska I
Przegl Lek; 2000; 57(3):143-6. PubMed ID: 10909282
[TBL] [Abstract][Full Text] [Related]
5. [Islet cell antibodies].
Hanafusa T
Rinsho Byori; 1995 May; 43(5):460-2. PubMed ID: 7783363
[TBL] [Abstract][Full Text] [Related]
6. Comparison of immunoassays for the detection of anti-GAD65 autoantibodies in patients with diabetes mellitus.
Pfützner A; Harzer O; Kunt T; Forst T; Abdollahnia N; Löbig M; Krauss H; Engelbach M; Kann P; Beyer J
Clin Lab; 2000; 46(5-6):275-9. PubMed ID: 10853236
[TBL] [Abstract][Full Text] [Related]
7. [The glutamic acid decarboxylase (GAD) antibodies and their clinical significance].
Ogata K; Ohta K; Kubo H; Yamaguchi A; Watanabe H
Rinsho Byori; 1995 May; 43(5):468-71. PubMed ID: 7783365
[TBL] [Abstract][Full Text] [Related]
8. A comparison of serum and EDTA plasma in the measurement of glutamic acid decarboxylase autoantibodies (GADA) and autoantibodies to islet antigen-2 (IA-2A) using the RSR radioimmunoassay (RIA) and enzyme linked immunosorbent assay (ELISA) kits.
Rahmati K; Lernmark A; Becker C; Foltyn-Zadura A; Larsson K; Ivarsson SA; Törn C
Clin Lab; 2008; 54(7-8):227-35. PubMed ID: 18942490
[TBL] [Abstract][Full Text] [Related]
9. Development of 2 alternative enzyme-linked immunosorbent assays for routine screening of glutamic acid decarboxylase autoantibodies.
Villalba A; Valdez SN; Iacono RF; Poskus E
Clin Chim Acta; 2007 Feb; 376(1-2):82-7. PubMed ID: 16963012
[TBL] [Abstract][Full Text] [Related]
10. Clinical evaluation of non-insulin-dependent diabetes mellitus patients with autoantibodies to glutamic acid decarboxylase.
Abiru N; Takino H; Yano M; Kawasaki E; Yamasaki H; Yamaguchi Y; Akazawa S; Nagataki S
J Autoimmun; 1996 Oct; 9(5):683-8. PubMed ID: 8933285
[TBL] [Abstract][Full Text] [Related]
11. [Early diagnosis of diabetes mellitus with the anti-GAD test].
Jungmann E
Fortschr Med; 1994 Dec; 112(35-36):8-9. PubMed ID: 7843686
[No Abstract] [Full Text] [Related]
12. Evaluation of islet-specific autoantibodies in Japanese patients with insulin-dependent diabetes mellitus: a comparison between autoantibodies to glutamic acid decarboxylase, autoantibodies to 64 kDa islet cell protein and islet cell antibodies.
Kawasaki E; Takino H; Yano M; Uotani S; Matsumoto K; Yamaguchi Y; Akazawa S; Nagataki S
J Autoimmun; 1994 Dec; 7(6):791-802. PubMed ID: 7888036
[TBL] [Abstract][Full Text] [Related]
13. Persistent GAD 65 antibodies in longstanding IDDM are not associated with residual beta-cell function, neuropathy or HLA-DR status.
Jaeger C; Allendörfer J; Hatziagelaki E; Dyrberg T; Bergis KH; Federlin K; Bretzel RG
Horm Metab Res; 1997 Oct; 29(10):510-5. PubMed ID: 9405979
[TBL] [Abstract][Full Text] [Related]
14. [Value of glutamic acid decarboxylase autoantibody detection for early diagnosis of latent autoimmune diabetes in adults].
Huang YY; Huang P; Lou HL
Di Yi Jun Yi Da Xue Xue Bao; 2003 Aug; 23(8):868-9. PubMed ID: 12919925
[TBL] [Abstract][Full Text] [Related]
15. Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease.
Tuomilehto J; Zimmet P; Mackay IR; Koskela P; Vidgren G; Toivanen L; Tuomilehto-Wolf E; Kohtamäki K; Stengård J; Rowley MJ
Lancet; 1994 Jun; 343(8910):1383-5. PubMed ID: 7910881
[TBL] [Abstract][Full Text] [Related]
16. Determination of anti GAD65 autoantibodies with an ELISA before and after standardization with the new international reference serum.
Pfützner A; Forst T; Ambrosch A; Schmitz H; Lichtwald K; Beyer J
Exp Clin Endocrinol Diabetes; 1995; 103(2):123-5. PubMed ID: 7553076
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune markers of diabetes in diabetic pregnancy.
Fallucca F; Tiberti C; Torresi P; Cardellini G; Sciullo E; D'Aliberti T; Napoli A; Di Mario U
Ann Ist Super Sanita; 1997; 33(3):425-8. PubMed ID: 9542275
[TBL] [Abstract][Full Text] [Related]
18. Developments in the prediction of type 1 diabetes mellitus, with special reference to insulin autoantibodies.
Franke B; Galloway TS; Wilkin TJ
Diabetes Metab Res Rev; 2005; 21(5):395-415. PubMed ID: 15895384
[TBL] [Abstract][Full Text] [Related]
19. Characterization of hydroxyl radical modified GAD65: a potential autoantigen in type 1 diabetes.
Khan MW; Sherwani S; Khan WA; Ali R
Autoimmunity; 2009 Feb; 42(2):150-8. PubMed ID: 19085183
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies against glutamic acid decarboxylase 65 in Japanese patients with insulin-dependent diabetes mellitus (IDDM).
Yano M; Moriuchi R; Kawasaki E; Watanabe M; Saito K; Takino H; Akazawa S; Miyamoto T; Nagataki S
J Autoimmun; 1995 Feb; 8(1):83-96. PubMed ID: 7734039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
